搜索结果：Epilepsy

Introduction: The HAS conducted a study in 2018 using the French National Health Data System (SNDS) on the care pathway of patients with epilepsy. This study used 2 algorithms to identify patients with epilepsy, based on hospitalization for epilepsy, insurance for chronic severe epilepsy, and antiepileptic drug (AE) dispensing, with exclusion of AEs not specific to epilepsy offering a low population estimate, or exclusion of dispensing in a context other than epilepsy (migraine, neuropathic pain, bipolar disorder, alcohol dependence, anxiety) offering a high population estimate. To study the characteristics of these 2 algorithms (low and high populations), we used data from CONSTANCES, a French generalist cohort and its control sample, which are matched to SNDS data. Method: This is a validation study of a method for identifying patients with epilepsy in the SNDS. The study population was patients identified as epileptic according to the algorithms defined in the introduction, applied over the year 2018 and the reference population was all patients for whom there is a mention of epilepsy (free text field) in the inclusion and/or follow-up questionnaires of the CONSTANCES cohort for

Slow wave sleep duration and spectral abnormalities are related to both epilepsy and depression, but it is unclear how depressive symptoms in patients with epilepsy are affected by slow wave sleep duration and clinical factors, and how the spectral characteristics of slow wave sleep reflect a potential interaction of epilepsy and depression. Long-term video-EEG monitoring was conducted in 51 patients with focal epilepsy, 13 patients with generalized epilepsy, and 9 patients without epilepsy. Slow wave sleep segments were manually marked in the EEG and duration as well as EEG power spectra were extracted. Depressive symptoms were documented with the Beck Depression Inventory (BDI). At least mild depressive symptoms (BDI>9) were found among 23 patients with focal epilepsy, 5 patients with generalised epilepsy, and 6 patients who had no epilepsy diagnosis. Slow wave sleep duration was shorter for patients with at least mild depressive symptoms (p=.004), independently from epilepsy diagnosis, antiseizure medication, age, and sex. Psychoactive medication was associated with longer slow wave sleep duration (p=.008). Frontal sigma band power (13-15 Hz) during slow wave sleep was higher

This study develops a medical AI-assisted diagnosis system based on deep learning, which provides intelligent diagnostic solutions for epilepsy, a disease that seriously threatens the life and health of patients. Epilepsy has sudden and unpredictable seizures. Traditional diagnostic methods mainly rely on doctors' manual interpretation of EEG, which is time-consuming and dependent by experience. In response to the above challenges, this study designed a dual-system intelligent diagnosis framework, which includes two core components: the main discrimination system and the verification system. The main discrimination system uses a deep learning model that combines the innovative Mamba architecture with the Bi-LSTM structure to integrate and analyze heterogeneous data to achieve extremely high diagnostic accuracy; the verification system provides an explainable diagnostic basis through the SHAP method to enhance the credibility of the results. This system establishes a cross-modal database to realize intelligent analysis of multi-source heterogeneous data-fusion EEG signals and clinical text data for epilepsy. The system outputs results based on diagnostic consistency and confidence l

Diagnosing epilepsy is challenging when routine EEGs lack interictal epileptiform discharges (IEDs). Intermittent photic stimulation (IPS) and hyperventilation (HV) can increase diagnostic yield, but their interpretation is subjective. We propose a reproducible pipeline that classifies EEG recordings acquired during stimulation procedures, using machine-learning features spanning temporal, spectral, wavelet, and connectivity domains, and a stacked ensemble to combine complementary feature sets. Performance is evaluated with leave-one-subject-out (LOSO) cross-validation on the TUH Epilepsy Corpus and a clinical Erasmus MC (EMC) cohort, including IED-free analyses on TUH. On TUH, ensembles achieve up to 97.8\% AUC / 93.1\% BAC on IED-free resting-state EEG and 94.1\% AUC / 86.8\% BAC on IED-free IPS. On EMC, IPS provides the strongest discrimination (79.4\% AUC / 73.9\% BAC), while HV performance benefits from stratifying subjects by responsiveness. These results indicate that stimulation-evoked activity, particularly IPS, contains meaningful discriminative information for IED-free epilepsy classification and that multi-domain ensembling improves robustness.

Epilepsy diagnosis and treatment require evidence-intensive reasoning across heterogeneous clinical knowledge, including biosignal patterns, genetic mechanisms, pharmacogenomics, treatment strategies, and patient outcomes. In this work, we present \textsc{EpiGraph}, a large-scale epilepsy knowledge graph and benchmark for evaluating knowledge-augmented clinical reasoning. \textsc{EpiGraph} integrates 48,166 peer-reviewed papers and seven clinical resources into a heterogeneous graph containing 24,324 entities and 32,009 evidence-grounded triplets across five clinical layers. Built upon this graph, \textsc{EpiBench} defines five clinically motivated tasks spanning clinical decision-making, EEG report generation, pharmacogenomic precision medicine, treatment recommendation, and deep research planning. We evaluate six LLMs under both standard and Graph-RAG settings. Results show that integrating \textsc{EpiGraph} consistently improves performance across all tasks, with the largest gains observed in pharmacogenomic reasoning (+30--41\%). Our findings demonstrate that structured epilepsy knowledge substantially enhances evidence-grounded clinical reasoning and provides a practical bench

Epileptic seizures are generated in cerebral networks that propagate ictal and interictal activity. The structure of cerebral networks underpinning epileptic activity can be inferred from diffusion-weighted MRI (DWI). However, publicly available DWI data in individuals with epilepsy are scarce, and processing is technically challenging due to scan-specific artifacts, limiting research progress. Here, we release raw DWI data from 216 individuals with epilepsy and 98 healthy controls. Subject identifiers align with our previous data release (IDEAS), which includes T1-weighted and FLAIR MRI, surgical details, and long-term seizure outcomes after surgery. Preprocessing reduced distortions and artifacts, while fully processed data include diffusion metric maps in native and template space. We also provide parcellated structural connectomes using multiple atlases and connectivity measures. To illustrate the utility of this IDEAS II data, we replicated ENIGMA consortium findings, observing widespread reductions of fractional anisotropy, particularly ipsilateral to the area of seizure onset. We further demonstrate localised abnormality, and network connectivity using streamline tractograph

Epilepsy is a chronic neurological condition characterized by recurrent seizures, with global prevalence estimated at 50 million people worldwide. While progress in high-throughput sequencing has allowed for broad-based transcriptomic profiling of brain tissues, the deciphering of these highly complex datasets remains one of the challenges. To address this issue, in this paper we propose a new analysis pipeline that integrates the power of deep learning strategies with GPU-acceleration computation for investigating Gene expression patterns in epilepsy. Specifically, our proposed approach employs GPT-2 XL, a transformer-based Large Language Model (LLM) with 1.5 billion parameters for genomic sequence analysis over the latest NVIDIA H100 Tensor Core GPUs based on Hopper architecture. Our proposed method enables efficient preprocessing of RNA sequence data, gene sequence encoding, and subsequent pattern identification. We conducted experiments on two epilepsy datasets including GEO accession GSE264537 and GSE275235. The obtained results reveal several significant transcriptomic modifications, including reduced hippocampal astrogliosis after ketogenic diet treatment as well as restored

Goal: Epilepsy remains under-diagnosed in low-income countries due to scarce neurologists and costly diagnostic tools. We propose a graph-based deep learning framework to detect epilepsy from low-cost Electroencephalography (EEG) hardware, tested on recordings from Nigeria and Guinea-Bissau. Our focus is on fair, accessible automatic assessment and explainability to shed light on epilepsy biomarkers. Methods: We model EEG signals as spatio-temporal graphs, classify them, and identify interchannel relationships and temporal dynamics using graph attention networks (GAT). To emphasize connectivity biomarkers, we adapt the inherently node-focused GAT to analyze edges. We also designed signal preprocessing for low-fidelity recordings and a lightweight GAT architecture trained on Google Colab and deployed on RaspberryPi devices. Results: The approach achieves promising classification performance, outperforming a standard classifier based on random forest and graph convolutional networks in terms of accuracy and robustness over multiple sessions, but also highlighting specific connections in the fronto-temporal region. Conclusions: The results highlight the potential of GATs to provide in

Epilepsy is a neurological illness that is characterised by continuous spasms of shaking, sometimes known as convulsions. Although there are effective treatments for epilepsy, such as drugs and surgery, there is still a group of individuals who have intractable epilepsy that fails to respond to standard methods. Intractable epilepsy is a severe neurological illness that ripples across the globe and impacts millions of individuals. It is extremely difficult to control intractable epilepsy, which is defined as the lack of response to two or more standard antiepileptic medication treatments. In recent years, the use of programmable electrical stimulation of the brain has shown promise as a digital treatment strategy for lowering seizure frequency in individuals with intractable epilepsy. In this research, the use of Amenable Neurostimulation (ANS) as part of a digital treatment strategy to intractable epilepsy is investigated. When applied to the brain, ANS uses a closed-loop system to selectively stimulate neurons in the affected areas, therefore lowering the frequency of seizures. In addition, the report describes the design and execution of a pilot research employing ANS to treat i

Accurate identification of the epileptogenic zone (EZ) is essential for seizure freedom after resective surgery in drug-resistant epilepsy, yet seizure freedom rates remain below 50%. We developed EpiiSLM, a dual foundation model system for EZ identification with stereo-electroencephalography (sEEG), by training a signal foundation model on 104,990 minutes of sEEG recordings from the Montreal Neurological Institute & Hospital, while leveraging all recordings regardless of surgical outcome and anchoring EZ biomarker extraction on non-epileptic signals. A language foundation model then integrates sEEG-derived outputs with multimodal clinical information to produce interpretable predictions. Under leave-one-patient-out evaluation, EpiiSLM achieved 0.978 contact-level positive predictive value (PPV), outperforming the seizure onset zone(SOZ)-as-EZ baseline by 15.1% (p < 0.05), and 100% region-level accuracy; on an external dataset, EpiiSLM achieved 0.857 contact-level PPV. EpiiSLM requires only one night of interictal sleep data, suggesting potential to reduce invasive sEEG monitoring duration and improve surgical outcomes.

Epilepsy and psychogenic non-epileptic seizures often present with similar seizure-like manifestations but require fundamentally different management strategies. Misdiagnosis is common and can lead to prolonged diagnostic delays, unnecessary treatments, and substantial patient morbidity. Although prolonged video-electroencephalography is the diagnostic gold standard, its high cost and limited accessibility hinder timely diagnosis. Here, we developed a low-cost, effective approach, EpiScreen, for early epilepsy detection by utilizing routinely collected clinical notes from electronic health records. Through fine-tuning large language models on labeled notes, EpiScreen achieved an AUC of up to 0.875 on the MIMIC-IV dataset and 0.980 on a private cohort of the University of Minnesota. In a clinician-AI collaboration setting, EpiScreen-assisted neurologists outperformed unaided experts by up to 10.9%. Overall, this study demonstrates that EpiScreen supports early epilepsy detection, facilitating timely and cost-effective screening that may reduce diagnostic delays and avoid unnecessary interventions, particularly in resource-limited regions.

Specialist epilepsy expertise is scarce in resource-constrained settings, making LLM-based decision support attractive for frontline clinicians managing longitudinal treatment. Such systems must adapt to local prescribing practice and know when to defer. We study this problem in Ugandan pediatric epilepsy care, predicting anti-seizure medication regimens from longitudinal unstructured clinic notes. Standard prompting achieves non-trivial agreement with physician prescriptions, but neurologist review shows that many errors reflect distribution-miscalibrated prescribing defaults rather than failures to parse the local record. We introduce MANANA, a non-parametric prompt-learning framework that learns local prescribing guidance from a small patient-level training set. MANANA converts observed prescription errors into auditable prompt memories, instantiated in single-agent and multi-agent variants, and improves over classical ML models, direct LLM prompting, and prompt-optimization baselines across two independently collected Ugandan cohorts. We further propose Bayesian prompt averaging, which converts the learned prompt trajectory into prescription likelihoods and an uncertainty-based

With large training datasets and massive amounts of computing sources, large language models (LLMs) achieve remarkable performance in comprehensive and generative ability. Based on those powerful LLMs, the model fine-tuned with domain-specific datasets posseses more specialized knowledge and thus is more practical like medical LLMs. However, the existing fine-tuned medical LLMs are limited to general medical knowledge with English language. For disease-specific problems, the model's response is inaccurate and sometimes even completely irrelevant, especially when using a language other than English. In this work, we focus on the particular disease of Epilepsy with Japanese language and introduce a customized LLM termed as EpilepsyLLM. Our model is trained from the pre-trained LLM by fine-tuning technique using datasets from the epilepsy domain. The datasets contain knowledge of basic information about disease, common treatment methods and drugs, and important notes in life and work. The experimental results demonstrate that EpilepsyLLM can provide more reliable and specialized medical knowledge responses.

In this study, we developed and tested machine learning models to predict epilepsy surgical outcome using noninvasive clinical and demographic data from patients. Methods: Seven dif-ferent categorization algorithms were used to analyze the data. The techniques are also evaluated using the Leave-One-Out method. For precise evaluation of the results, the parameters accuracy, precision, recall and, F1-score are calculated. Results: Our findings revealed that a machine learning-based presurgical model of patients' clinical features may accurately predict the outcome of epilepsy surgery in patients with drug-resistant lesional epilepsy. The support vector machine (SVM) with the linear kernel yielded 76.1% in terms of accuracy could predict results in 96.7% of temporal lobe epilepsy (TLE) patients and 79.5% of extratemporal lobe epilepsy (ETLE) cases using ten clinical features. Significance: To predict the outcome of epilepsy surgery, this study recommends the use of a machine learning strategy based on supervised classification and se-lection of feature subsets data mining. Progress in the development of machine learning-based prediction models offers optimism for personalised medicine

Epilepsy is a prevalent neurological disease with millions of patients worldwide. Many patients have turned to alternative medicine due to the limited efficacy and side effects of conventional antiepileptic drugs. In this study, we developed a computational approach to optimize herbal epilepsy treatment through AI-driven analysis of global natural products and statistically validated randomized controlled trials (RCTs). Our intelligent prescription system combines machine learning (ML) algorithms for herb-efficacy characterization, Bayesian optimization for personalized dosing, and meta-analysis of RCTs for evidence-based recommendations. The system analyzed 1,872 natural compounds from traditional Chinese medicine (TCM), Ayurveda, and ethnopharmacological databases, integrating their bioactive properties with clinical outcomes from 48 RCTs covering 48 epilepsy conditions (n=5,216). Using LASSO regression and SHAP value analysis, we identified 17 high-efficacy herbs (e.g., Gastrodia elata [using é for accented characters], Withania somnifera), showing significant seizure reduction (p$<$0.01, Cohen's d=0.89) with statistical significance confirmed by multiple testing (p$<$0.00

Epilepsy is a neurological disorder characterized by seizures and epileptic events intertwined with religious and personal beliefs since prehistoric times. This review paper explores the historical context and challenges in defining epilepsy. The formal definition was established twenty years ago, and the multifaceted causes of this neurological disorder. It aims to pave the way for personalised therapeutic strategies, research advancements, and informed public health planning to enhance the lives of those affected by this complex neurological condition. In addition, this review paper focuses on the mechanisms and etiologies of epileptogenesis, categorizing them by mechanisms and the underlying causes of the disorder. The review paper provides a brief overview of the current state of the art in the diagnosis, diagnosis, treatment, and treatment of epileptiform seizures.

Social media platforms, particularly Reddit's r/Epilepsy community, offer a unique perspective into the experiences of individuals with epilepsy (PWE) and their caregivers. This study analyzes 57k posts and 533k comments to explore key themes across demographics such as age, gender, and relationships. Our findings highlight significant discussions on epilepsy-related challenges, including depression (with 39.75\% of posts indicating severe symptoms), driving restrictions, workplace concerns, and pregnancy-related issues in women with epilepsy. We introduce a novel engagement metric, F(P), which incorporates post length, sentiment scores, and readability to quantify community interaction. This analysis underscores the importance of integrated care addressing both neurological and mental health challenges faced by PWE. The insights from this study inform strategies for targeted support and awareness interventions.

Predicting seizure freedom is essential for tailoring epilepsy treatment. But accurate prediction remains challenging with traditional methods, especially with diverse patient populations. This study developed a deep learning-based graph neural network (GNN) model to predict seizure freedom from stereo electroencephalography (sEEG) data in patients with refractory epilepsy. We utilized high-quality sEEG data from 15 pediatric patients to train a deep learning model that can accurately predict seizure freedom outcomes and advance understanding of brain connectivity at the seizure onset zone. Our model integrates local and global connectivity using graph convolutions with multi-scale attention mechanisms to capture connections between difficult-to-study regions such as the thalamus and motor regions. The model achieved an accuracy of 92.4% in binary class analysis, 86.6% in patient-wise analysis, and 81.4% in multi-class analysis. Node and edge-level feature analysis highlighted the anterior cingulate and frontal pole regions as key contributors to seizure freedom outcomes. The nodes identified by our model were also more likely to coincide with seizure onset zones. Our findings unde

Objective: The circadian rhythm synchronizes physiological and behavioural patterns with the 24-hour light-dark cycle. Disruption to the circadian rhythm is linked to various health conditions, though optimal methods to describe these disruptions remain unclear. An emerging approach is to examine the intra-individual variability in measurable properties of the circadian rhythm over extended periods. Epileptic seizures are modulated by circadian rhythms, but the relevance of circadian rhythm disruption in epilepsy remains unexplored. Our study investigates intra-individual circadian variability in epilepsy and its relationship with seizures. Methods: We retrospectively analyzed over 70,000 hours of wearable smartwatch data (Fitbit) from 143 people with epilepsy (PWE) and 31 healthy controls. Circadian oscillations in heart rate time series were extracted, daily estimates of circadian period, acrophase, and amplitude properties were produced, and estimates of the intra-individual variability of these properties over an entire recording were calculated. Results: PWE exhibited greater intra-individual variability in period (76 min vs. 57 min, d=0.66, p<0.001) and acrophase (64 min v